Stephanie Ailey

Bio:

Stephanie Ailey is Vice President of Business Development at DM Clinical, where she leverages more than 20 years of experience in healthcare, program management, and clinical research to build strategic partnerships with sponsors, CROs, and biotechnology companies. She is responsible for driving business growth across DM Clinical's national site network by connecting innovative research programs with high-performing investigative sites known for quality, operational excellence, rapid startup, and access to diverse patient populations.

Known for her collaborative leadership and ability to cultivate lasting relationships, Stephanie believes the strongest partnerships are built on trust, transparency, and a shared commitment to advancing patient care. She is recognized for developing creative solutions to complex clinical development challenges while helping sponsors accelerate study execution and achieve successful enrollment outcomes.

Stephanie's passion for clinical research is rooted in firsthand experience, including being part of the study site that enrolled the first patient globally in a Phase 3 COVID-19 trial—a defining milestone that reinforced the impact of collaboration, innovation, and dedication across research teams. She is deeply committed to expanding access to clinical trials, advancing diversity in research, and helping bring life-changing therapies to patients faster.

Combining strategic vision with an authentic, solutions-oriented approach, Stephanie brings energy, integrity, and a "let's find a way" mindset to every partnership. Her proven ability to align sponsors, CROs, investigators, and research sites has made her a trusted industry partner and a driving force behind DM Clinical's continued growth and innovation.